Horizon Technology Finance stock crosses its 200-day average

Published on 10/14/2026 at 05:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The 200-day average stood at USD 4.50 on October 13, 2026. A USD 5.00 consensus target was reported for Horizon Technology Finance stock.

Technical level and dividend dates

Horizon Technology Finance reached USD 4.63 against its USD 4.50 200-day average on October 13, 2026.
Second-quarter revenue was USD 25.05 million versus USD 25.22 million expected.
Horizon Technology Finance stock last traded at USD 4.58 on Nasdaq on October 13, 2026.
The company declared a USD 0.06 monthly distribution payable on December 15, 2026.

HRZN, US44045A1025, Illustration mit AI erstellt.

Horizon Technology Finance (ISIN US44045A1025) crossed its 200-day average on October 13, 2026, reaching USD 4.63 against an average of USD 4.50, as MarketBeat reported. The move puts the venture lender's latest market level alongside a cautious analyst consensus and a quarterly result affected by merger costs.

Stock clears a key technical level

MarketBeat said the stock traded as high as USD 4.63 before last trading at USD 4.58 on October 13, 2026, while the 200-day average stood at USD 4.50. The same report listed a Hold consensus, an average target of USD 5.00, and a target range of USD 4.50 to USD 5.50.

The rating mix was one Buy, five Holds and one Sell. That distribution makes the technical move a measured signal rather than a broad change in analyst conviction, particularly because the average target remains above the reported last price.

What does the Q2 setup show?

Horizon reported USD 25.05 million of revenue for the second quarter of 2026, compared with USD 25.22 million expected, and reported earnings per share of USD 0.11 against USD 0.13 consensus, according to MarketBeat.

In its second-quarter 2026 earnings call, Yahoo Finance reported that net investment income was USD 0.11 per share, versus USD 0.19 in the first quarter of 2026. Excluding USD 4.40 million of non-recurring merger expenses, net investment income was USD 0.18 per share.

Three recent financing milestones

Horizon provided a USD 15.00 million loan facility to Bioness Medical on September 2, 2026, according to its investor-relations site. The company also announced a RoHo Joint Venture loan facility of up to USD 30.00 million for NeoVolta on September 10, 2026.

On August 4, 2026, Horizon announced regular distributions totaling USD 0.18 per share for October through December 2026 and special distributions totaling USD 0.09 per share. The second-quarter call also said the company funded nine debt investments totaling USD 73.00 million during the quarter.

Dates shape the next test

Horizon set a USD 0.06 monthly distribution for shareholders of record on November 17, 2026, payable December 15, 2026, according to MarketBeat. The distribution schedule gives the technical signal a defined income-related date to watch.

On Nasdaq, Horizon Technology Finance last traded at USD 4.58 on October 13, 2026. The combination of a USD 4.50 technical average, a USD 5.00 consensus target and second-quarter earnings of USD 0.11 per share leaves operating execution and portfolio credit quality central to the next valuation discussion.